NYSE - Delayed Quote • USD
Novo Nordisk A/S (NVO)
At close: April 24 at 4:00 PM EDT
Pre-Market: 6:45 AM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
108,908,000.00
108,908,000.00
78,887,000.00
55,000,000.00
51,951,000.00
Investing Cash Flow
-43,892,000.00
-43,892,000.00
-24,918,000.00
-31,605,000.00
-22,436,000.00
Financing Cash Flow
-63,158,000.00
-63,158,000.00
-51,797,000.00
-25,493,000.00
-32,244,000.00
End Cash Position
14,392,000.00
14,392,000.00
12,653,000.00
10,719,000.00
12,226,000.00
Capital Expenditure
-38,896,000.00
-38,896,000.00
-14,753,000.00
-7,385,000.00
-22,081,000.00
Issuance of Debt
--
--
11,215,000.00
22,160,000.00
5,682,000.00
Repayment of Debt
-1,467,000.00
-1,467,000.00
-13,623,000.00
-6,689,000.00
-950,000.00
Repurchase of Capital Stock
-29,924,000.00
-29,924,000.00
-24,086,000.00
-19,447,000.00
-16,855,000.00
Free Cash Flow
70,012,000.00
70,012,000.00
64,134,000.00
47,615,000.00
29,870,000.00
12/31/2020 - 4/30/1981
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VKTX Viking Therapeutics, Inc.
65.07
+0.22%
VRTX Vertex Pharmaceuticals Incorporated
400.76
-1.02%
CRSP CRISPR Therapeutics AG
55.65
-1.35%
MRNA Moderna, Inc.
108.85
+0.89%
RXRX Recursion Pharmaceuticals, Inc.
7.94
+3.12%
REGN Regeneron Pharmaceuticals, Inc.
906.54
-0.09%
ALT Altimmune, Inc.
7.08
-6.47%
NVAX Novavax, Inc.
4.1500
-0.95%
MDGL Madrigal Pharmaceuticals, Inc.
204.65
-6.29%
IBRX ImmunityBio, Inc.
4.8200
-12.20%